BEDFORD, Mass., Nov. 7 /PRNewswire-FirstCall/ -- Insulet Corporation (Nasdaq: PODD), the manufacturer and marketer of the OmniPod(R) Insulin Management System, announced plans to release its financial results for the third quarter 2007 on Wednesday, November 14, 2007 after the close of the financial markets.
Insulet will also host a conference call at 8:00 a.m. Eastern Time on Thursday, November 15, 2007 to discuss its third quarter 2007 financial results. During the conference call, material information concerning the Company, its operations, strategies and prospects may be discussed.
To listen to the conference call, please dial 800.688.0836 for domestic callers and 617.614.4072 for international callers. The passcode is 63605515. A replay of the conference call will be available two hours after the start of the call through December 15, 2007 by dialing 888-286-8010 (domestic) and 617-801-6888 (international), passcode 89284526. An online archive of the conference call will also be available by accessing the Investor Information section of the company's website at http://investors.insulet.com.
About Insulet Corporation
Insulet Corporation is an innovative medical device company dedicated to improving the lives of people with diabetes. The Company's OmniPod Insulin Management System is a revolutionary, discreet and easy-to-use insulin infusion system that features two easy-to-use parts with no tubing and fully- automated cannula insertion. Through the OmniPod System, Insulet seeks to expand the use of continuous subcutaneous insulin infusion (CSII) therapy among people with insulin-dependent diabetes. Founded in 2000, Insulet is based in Bedford, MA.
Stephanie Marks for Insulet Corporation
|SOURCE Insulet Corporation|
Copyright©2007 PR Newswire.
All rights reserved